Eyebright Medical Technology (Beijing) Co., Ltd. (688050.SS)
CNY 88.82
(-1.03%)
CNY 88.82
(-1.03%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 226.26 Million | 250.13 Million | 219.29 Million | 123.35 Million | 50.49 Million | 31.82 Million |
| Net Income | 303.97 Million | 227.23 Million | 167.75 Million | 96.11 Million | 65.75 Million | 20.3 Million |
| Depreciation & Amortization | 86.45 Million | 43.34 Million | 32.03 Million | 26.66 Million | 22.39 Million | 13.75 Million |
| Deferred income taxes | -10.7 Million | 7.9 Million | -8.42 Million | 171.67 Thousand | -13.55 Million | - |
| Stock-based compensation | 11.07 Million | 15.71 Million | 12.01 Million | - | - | - |
| Change in working capital | -167.18 Million | -39.26 Million | 11.11 Million | -137.1 Thousand | -39.55 Million | -19.24 Million |
| Other non-cash items | 353.81 Million | -6.64 Million | 4.79 Million | 707.75 Thousand | 1.89 Million | 17 Million |
| Investing Cash Flow | 19.02 Million | -307.84 Million | -420.36 Million | -587.71 Million | 63.97 Million | -272.21 Million |
| Investments in PPE | -370.34 Million | -271.03 Million | -311.21 Million | -118.73 Million | -141.61 Million | -71.8 Million |
| Acquisitions | -46.59 Million | -27.38 Million | - | 27.27 Thousand | 500.00 | 71.8 Million |
| Investment purchases | -1.14 Billion | -2.4 Billion | -1.98 Billion | -774.98 Million | -500.00 | -555.29 Million |
| Sales/Maturities of investments | 1.58 Billion | 2.37 Billion | 1.88 Billion | 301.92 Million | 203.02 Million | 354.89 Million |
| Other Investing Activities | -3.67 Million | 20.53 Million | -6.55 Million | 4.05 Million | 2.56 Million | -71.8 Million |
| Financing Cash Flow | -63.56 Million | -65.07 Million | 137.73 Million | 804.72 Million | 14.89 Million | 276.41 Million |
| Debt repayment | -1.91 Million | -3.6 Million | -143.37 Million | -444 Thousand | -7.71 Million | -35.76 Million |
| Dividends payments | -53.64 Million | -38.91 Million | -29.44 Million | -12.97 Thousand | -264.99 Thousand | -818.74 Thousand |
| Common Stock Repurchased | - | - | - | 18.1 Million | 5.02 Million | - |
| Common Stock Issuance | - | - | - | -18.1 Million | -5.02 Million | - |
| Other Financing Activities | -2.66 Million | -17.02 Million | 311.63 Million | 805.18 Million | 22.87 Million | 312.99 Million |
| Accounts receivables | -103.51 Million | -45.75 Million | 1.12 Million | 18.11 Million | -14.77 Million | -8.48 Million |
| Accounts payables | 21.45 Million | 21.4 Million | 15.07 Million | -20.09 Million | 13.19 Million | - |
| Inventory | -85.12 Million | -22.81 Million | 3.34 Million | 1.67 Million | -24.41 Million | -20.03 Million |
| Other working capital | 1.00 | 7.9 Million | -8.42 Million | 171.67 Thousand | -13.55 Million | 795.35 Thousand |
| Cash at beginning of period | 354.89 Million | 472.87 Million | 536.84 Million | 196.32 Million | 66.96 Million | 30.94 Million |
| Cash at end of period | 536.65 Million | 350.04 Million | 472.87 Million | 536.84 Million | 196.32 Million | 66.96 Million |
| Capital Expenditure | -370.34 Million | -271.03 Million | -311.21 Million | -118.73 Million | -141.61 Million | -71.8 Million |
| Effect of forex changes on cash | 40 Thousand | -41.94 Thousand | -635.38 Thousand | 148.42 Thousand | -5754.79 | - |
| Net cash flow / Change in cash | 181.75 Million | -122.82 Million | -63.96 Million | 340.51 Million | 129.36 Million | 36.02 Million |
| Free Cash Flow | -144.07 Million | -20.89 Million | -91.92 Million | 4.62 Million | -91.11 Million | -39.98 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 105.13 Million | 102.9 Million | 52 Million | 303.97 Million | 88.78 Million | 84.78 Million |
| Depreciation & Amortization | 34.03 Million | 34.03 Million | 25.55 Million | 86.45 Million | -30.63 Million | 17.67 Million |
| Deferred income taxes | -3.03 Million | - | 165.17 Million | -10.7 Million | -52.72 Million | 40.98 Million |
| Stock-based compensation | 3.27 Million | - | 11.07 Million | 11.07 Million | -7.35 Million | 7.35 Million |
| Change in working capital | -178.9 Million | - | -176.24 Million | -167.18 Million | 87.26 Million | -87.26 Million |
| Other non-cash items | -71.72 Thousand | -48.81 Million | 7.33 Million | 353.81 Million | -34.4 Million | -10.86 Million |
| Investing Cash Flow | -116.41 Million | -185.35 Million | -105.47 Million | 19.02 Million | 251.95 Million | -48.02 Million |
| Investments in PPE | -93.74 Million | -126.24 Million | -187.74 Million | -370.34 Million | -72.26 Million | -61.6 Million |
| Acquisitions | 1.18 Million | 100.00 | -56.62 Million | -46.59 Million | - | 4200.00 |
| Investment purchases | 18.41 Million | -79 Million | 119.44 Million | -1.14 Billion | -219.85 Million | -500 Million |
| Sales/Maturities of investments | 41.7 Million | 20 Million | 50.04 Million | 1.58 Billion | 513.44 Million | 513.57 Million |
| Other Investing Activities | 107.9 Thousand | -107.8 Thousand | -30.59 Million | -3.67 Million | 30.62 Million | 0.73 |
| Financing Cash Flow | 288.91 Million | -37.5 Million | 377.31 Thousand | -63.56 Million | -12.24 Million | -42.08 Million |
| Debt repayment | -341.11 Million | -12.92 Million | -4.47 Million | -1.91 Million | -7.8 Million | -10.35 Million |
| Dividends payments | -51.5 Million | -4 Million | -4.14 Million | -53.64 Million | -1.68 Million | -53.64 Million |
| Common Stock Repurchased | -20.04 Million | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 19.34 Million | -24.58 Million | 10.2 Million | -2.66 Million | -2.75 Million | 22.28 Million |
| Accounts receivables | -150.07 Million | - | -103.51 Million | -103.51 Million | 57.12 Million | -57.12 Million |
| Accounts payables | - | - | - | 21.45 Million | 7.35 Million | -7.35 Million |
| Inventory | -33.26 Million | - | -85.12 Million | -85.12 Million | 30.13 Million | -30.13 Million |
| Other working capital | 4.43 Million | - | 12.38 Million | 1.00 | -7.35 Million | 7.35 Million |
| Cash at beginning of period | 367.87 Million | 536.65 Million | 556.85 Million | 354.89 Million | 261.35 Million | 298.75 Million |
| Cash at end of period | 608.39 Million | 367.87 Million | 536.65 Million | 536.65 Million | 552 Million | 261.35 Million |
| Capital Expenditure | -93.74 Million | -126.24 Million | -187.74 Million | -370.34 Million | -72.26 Million | -61.6 Million |
| Effect of forex changes on cash | 26.23 Thousand | -400.00 | 5333.49 | 40 Thousand | -669.28 | 44.99 Thousand |
| Net cash flow / Change in cash | 240.51 Million | -168.77 Million | -20.19 Million | 181.75 Million | 290.64 Million | -37.39 Million |
| Free Cash Flow | -25.75 Million | -72.16 Million | -102.84 Million | -144.07 Million | -21.33 Million | -8.93 Million |
FQVTF
GDLNF
STRLGUA
BQST
688606
BAF